167 related articles for article (PubMed ID: 9692126)
21. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol.
Vidgren M; Silvasti M; Korhonen P; Kinkelin A; Frischer B; Stern K
Arzneimittelforschung; 1995 Jan; 45(1):44-7. PubMed ID: 7893268
[TBL] [Abstract][Full Text] [Related]
22. Clinical equivalence between salbutamol hydrofluoroalkane pMDI and salbutamol Turbuhaler at the same cumulative microgram doses in paediatric patients.
Gustafsson P; Källman S; Whitehead PJ
Respir Med; 2002 Nov; 96(11):957-9. PubMed ID: 12418596
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma.
Bondesson E; Friberg K; Soliman S; Löfdahl CG
Respir Med; 1998 Feb; 92(2):325-30. PubMed ID: 9616533
[TBL] [Abstract][Full Text] [Related]
24. Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler DPI.
Newhouse MT; Patel P; Parry-Billings M
Eur Respir J; 2003 May; 21(5):816-20. PubMed ID: 12765427
[TBL] [Abstract][Full Text] [Related]
25. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
[TBL] [Abstract][Full Text] [Related]
26. Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI.
Broeders ME; Molema J; Hop WC; Folgering HT
Eur J Clin Pharmacol; 2005 Feb; 60(12):837-41. PubMed ID: 15625613
[TBL] [Abstract][Full Text] [Related]
27. Comparative in vivo lung delivery of hydrofluoroalkane-salbutamol formulation via metered-dose inhaler alone, with plastic spacer, or with cardboard tube.
Fowler SJ; Wilson AM; Griffiths EA; Lipworth BJ
Chest; 2001 Apr; 119(4):1018-20. PubMed ID: 11296163
[TBL] [Abstract][Full Text] [Related]
28. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI.
Seberová E; Andersson A
Respir Med; 2000 Jun; 94(6):607-11. PubMed ID: 10921767
[TBL] [Abstract][Full Text] [Related]
29. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma.
Dockhorn R; Vanden Burgt JA; Ekholm BP; Donnell D; Cullen MT
J Allergy Clin Immunol; 1995 Jul; 96(1):50-6. PubMed ID: 7622763
[TBL] [Abstract][Full Text] [Related]
30. Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study.
Ostrom NK; Taveras H; Iverson H; Pearlman DS
Respir Med; 2015 Nov; 109(11):1410-5. PubMed ID: 26475054
[TBL] [Abstract][Full Text] [Related]
31. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
Jonkers RE; Bantje TA; Aalbers R
Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Hajiro T; Mishima M; Izumi T
Respiration; 1999; 66(2):119-23. PubMed ID: 10202314
[TBL] [Abstract][Full Text] [Related]
33. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.
Tomlinson HS; Corlett SA; Allen MB; Chrystyn H
Br J Clin Pharmacol; 2005 Dec; 60(6):605-10. PubMed ID: 16305584
[TBL] [Abstract][Full Text] [Related]
34. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
[TBL] [Abstract][Full Text] [Related]
35. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
Yates DH; Peters MJ; Keatings V; Thomas PS; Barnes PJ
Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
[TBL] [Abstract][Full Text] [Related]
38. Bronchodilating effects of salbutamol from a novel inhaler Airmax.
Middle MV; Terblanché J; Perrin VL; Hertog MG
Respir Med; 2002 Jul; 96(7):493-8. PubMed ID: 12194632
[TBL] [Abstract][Full Text] [Related]
39. Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler.
Robertson CF; Norden MA; Fitzgerald DA; Connor FL; Van Asperen PP; Cooper PJ; Francis PW; Allen HD
J Paediatr Child Health; 1998 Apr; 34(2):142-6. PubMed ID: 9588637
[TBL] [Abstract][Full Text] [Related]
40. Salbutamol dry powder inhaler: efficacy, tolerability, and acceptability study.
O'Callaghan C; Everard ML; Bush A; Hiller EJ; Ross-Russell R; O'Keefe P; Weller P
Pediatr Pulmonol; 2002 Mar; 33(3):189-93. PubMed ID: 11836798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
